Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) EPS (Weighted Average and Diluted): 2010-2013

Historic EPS (Weighted Average and Diluted) for Tenax Therapeutics (TENX) over the last 2 years, with Apr 2013 value amounting to -$6.38.

  • Tenax Therapeutics' EPS (Weighted Average and Diluted) rose 52.46% to -$6.38 in Q2 2013 from the same period last year, while for Apr 2013 it was -$6.87, marking a year-over-year increase of 52.39%. This contributed to the annual value of -$1.15 for FY2024, which is 96.30% up from last year.
  • Latest data reveals that Tenax Therapeutics reported EPS (Weighted Average and Diluted) of -$6.38 as of Q2 2013, which was down 4,457.14% from -$0.14 recorded in Q1 2013.
  • In the past 5 years, Tenax Therapeutics' EPS (Weighted Average and Diluted) ranged from a high of -$0.09 in Q4 2010 and a low of -$13.42 during Q2 2012.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.26 (2011), whereas its average is -$2.15.
  • As far as peak fluctuations go, Tenax Therapeutics' EPS (Weighted Average and Diluted) tumbled by 11,083.33% in 2012, and later skyrocketed by 64.10% in 2013.
  • Tenax Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.09 in 2010, then plummeted by 222.22% to -$0.29 in 2011, then soared by 55.17% to -$0.13 in 2012, then skyrocketed by 52.46% to -$6.38 in 2013.
  • Its EPS (Weighted Average and Diluted) stands at -$6.38 for Q2 2013, versus -$0.14 for Q1 2013 and -$0.13 for Q4 2012.